We evaluated the usefulness of left atrial volume index (LAVI) and the degree of changes in LAVI (delta LAVI) during hospitalization for the prediction of prognosis after acute myocardial infarction (AMI).
Introduction
Prognostic factors for acute myocardial infarction (AMI) patients, include age, gender, diabetes mellitus, and history of previous myocardial infarction. 1, 2 Prognostic indicators on echocardiography have been reported to be left ventricular ejection fraction (LVEF), 3 the ratio of peak early to late diastolic transmitral flow velocity (E/A), deceleration time (DcT), 4, 5 and the ratio of early transmitral velocity to the early mitral annular velocity (E/e ′ ). 6, 7 Left atrial volume index (LAVI) on admission has been also an indicator of prognosis, and values of 32.0 mL/m 2 or more have been associated with a poor prognosis. 8, 9 The progression of diastolic dysfunction due to left ventricular remodelling after AMI is also associated with a poor prognosis. 10 However, the clinical usefulness of LAVI at discharge in patients with AMI is not fully understood. LAVI changes gradually due to diastolic dysfunction, such as haemoglobin (Hb) A1C (a long-term biomarker of average metabolic state). 11 On admission, left ventricular remodelling after AMI is not yet advanced, and there is a possibility that LAVI has not changed yet. It is reasonable to measure LAVI again at discharge because left ventricular remodelling at discharge is more likely to be advanced than that on admission. In addition, there are cases in which LAVI already shows an increase on admission due to the rise of LVEDP, but LVEDP would decrease with appropriate treatments and LAVI declines. On the other hand, there are also cases in which LAVI is not increased on admission, while diastolic dysfunction induced by left ventricular remodelling progresses with a marked increase in LAVI resulting. Therefore, the importance of the degree of changes in LAVI values (delta LAVI) from admission to discharge was determined in the present study.
Methods
We studied 205 consecutive patients (median age 65 years, 173 men) with first AMI admitted to the Fujita Health University Hospital Coronary Care Unit between January 2006 and December 2009, excluding those with advanced valvular disease or, atrial fibrillation (Af). AMI was defined by the presence of at least two of the following criteria: typical ischaemic symptoms at least ≥15 min, electrocardiographic changes (ST-segment depression or elevation of at least 0.5 mm, T-wave inversion of at least 3 mm in at least three leads, left bundle-branch block), and elevated levels of cardiac markers. Patients were followed for a median of 26 months (0 -57 months). Echocardiography was performed within 2 days of hospital admission (median of 1 day) and at the time of discharge (median of 16 days). All studies were performed by experienced sonographers and reviewed by staff cardiologists with advanced training in echocardiography. Philips SONOS5500, 7500 or iE33, with an S3 or S5-1 probe, was used. LVEF was measured from the apical four-and two-chamber views by the biplane Simpson method. Mitral inflow was assessed in the apical four-chamber view, using a pulsed-wave Doppler beam aligned parallel to the direction of the flow, and the sample volume at the leaflet tips. From the mitral inflow profile, the E-and A-wave peak velocities and DcT of E-wave were measured. The E/A ratio was calculated from the ratio of the peak of E-wave and A-wave ( Figure 1 ). Doppler tissue imaging of the mitral annulus was obtained from the apical four-chamber view, using a 1-to 2-mm sample volume placed in the septal mitral valve annulus. It measured e ′ , and E/e ′ was calculated ( Figure 2 ). LA volume in end-systole from the frame preceding mitral valve opening was assessed by the biplane Simpson method from the apical fourand two-chamber views, and the volume was corrected for body surface area (BSA) (Figure 3) .
Delta LAVI was calculated by subtracting LAVI on admission from that at discharge. The study endpoints were major cardiac events (MACE); cardiac death due to heart failure and heart failure hospitalization. The study subjects were divided into two groups, respectively, according to the optimal cut-off values of LAVI (32.0 mL/m The clinical and echocardiographic characteristics were compared by x 2 analysis for categorical variables and by Mann-Whitney U test for echocardiography and other continuous variables. Continuous data were expressed as median and interquartile range. The survival curves were produced using the Kaplan-Meier method. The log-rank test was used to compare survival curves. A P-value of ,0.05 was considered significant. JMP version 8.0 (&2008 SAS Institute Inc., Cary, NC, USA) software was used for all statistical analyses ( Figure 4 ).
Results

MACE occurred in 29 patients (14%)
. Two patients died of heart failure, and 27 patients were hospitalized due to congestive heart failure.
With regard to patient background characteristics, MACE occurred significantly more frequently in women(men: 69 vs. 
Discussion
Left ventricular diastolic dysfunction progresses due to progressive left ventricular remodelling after AMI and leads to a rise in LVEDP.
Because the left atrium is influenced by LVEDP while the mitral valve is open, left atrium pressure increases due to the persistent rise of LVEDP, and LAVI increases. After AMI progressive diastolic dysfunction due to left ventricular remodelling and increasing LVEDP have been reported to indicate a poor prognosis, 12 and in the present study as well the main determinants of the left ventricular remodelling, anteroseptal MI, infarct size, and the re-vascularization procedure for the culprit artery all showed significant differences between the MACE group and no-MACE group. Moreover, significant differences were found on echocardiography in LVEF, LVDd, LVDs, DcT, and E/e ′ that reflected the more advanced left ventricular remodelling, diastolic dysfunction, and LVEDP between the MACE group and no-MACE group. Significant differences were similarly noted in the previously reported prognostic factors of age, sex, eGFR, Hb, and BNP at discharge. The frequency of beta-blocker and diuretic use was significantly higher in the MACE group. This was surmised to be due to the fact that in numerous cases in this group heart failure with elevated LVEDP was present from the admission period, with these agents then introduced to control the heart failure ( Tables 1 and 2 ). LAVI on admission and E/e ′ on admission have been widely used as indicators for prognosis in AMI patients. 6, 8, 9 In this study LAVI on admission differed significantly between the MACE and no-MACE groups, while E/e ′ on admission did not differ significantly between them. However, in the present analysis, LAVI on admission and E/e ′ on admission were not significant prognostic factors in the multivariate logistic regression analysis.
Moller et al. 8 and Beinart et al. 9 reported that LAVI on admission was a powerful predictor of mortality and remained an independent predictor after AMI, although, in our study it was not. A difference between this study and Moller's and Beinart's studies is that, the endpoint in the latter was all-cause mortality, whereas in our study it was cardiac death and hospitalization due to heart BSA, body surface area; BMI, body mass index; HT, hypertation; HL, hyperlipidaemia; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; Hb, haemoglobin; ARB, angiotensin receptor blocker; ACE, angiotensin converting enzyme; HMG-CoA, hydroxyl-3-methylglutaryl CoA; STEMI, ST-segment elevation myocardial infarction; TIMI, thrombolysis in myocardial infarction trial; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; BNP, brain natriuretic peptide; Peak CK, peak creatine kinase; Peak Tn-I, peak troponin-I; LVEF, left ventricular ejection fraction; LVDd, left ventricular dimension at end-diastole; LVDs, left ventricular dimension at end-systole; E/A, the ratio of peak early to late diastolic transmitral flow velocity; DcT, deceleration time; E/e ′ , the ratio of early transmitral velocity to the early mitral annular velocity; LAVI, left atrial volume index.
higher proportion of patients whose diastolic function on admission was worse than that in this study.
Hillis et al. 6 reported that E/e ′ on admission was a powerful predictor of mortality and remained an independent predictor after AMI, while in this study it was not. These two studies differed in that the endpoint of Hillis' study was all-cause mortality. And patients with prior AMI, and moderate or severe MR were all excluded in the present study, but not in Hillis' study, while the average age was older than in our study. Patients with DcT ≤ 140 ms and E/e ′ ≥ 15 on admission echocardiography were both more numerous in Hillis' study. Similarly, the proportion of patients with diastolic dysfunction on admission was higher in Hillis' study than in ours. LAVI at discharge showed significant differences between the MACE and no-MACE groups, and was identified as prognostic factors in the multivariate analysis. LAVI at discharge was a more accurate indicator of prognosis than LAVI on admission, probably because left ventricular remodelling at discharge is more advanced than that on admission. LAVI at discharge was found to be a powerful prognostic factor in this study. Delta LAVI differed significantly between the MACE and no-MACE groups, and became a significant prognostic factor on multivariate analysis.
Limitations of this study include the fact that LAVI cannot be applied in the presence of severe mitral valve disease or Af, while blurred images or complicated left atrial volume measurements by echocardiography make it difficult to accurately measure the left atrial volume. We considered the small number of deaths to be attributable to the fact that we counted only those deaths due to heart failure, while excluding the deaths due to fatal arrhythmia immediately after AMI and those due to other causes. Therefore, heart failure hospitalization accounted for the majority of MACE. The follow-up period was modest, and a longer period might be necessary to draw more definite conclusions.
Conclusion
Both LAVI at discharge and delta LAVI would be the useful indicators for prognosis in AMI patients. E/e ′ , the ratio of early transmitral velocity to the early mitral annular velocity.
